Bone remodelling at a glance

Journal of Cell Science

Volumn 124, Issue 7, 2011, Pages 991-998

  Crockett, Julie C ^a   Rogers, Michael J ^a   Coxon, Fraser P ^a   Hocking, Lynne J ^a   Helfrich, Miep H ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DENOSUMAB; HIGH MOBILITY GROUP B1 PROTEIN; ODANACATIB; SCLEROPROTEIN; WNT PROTEIN;

ARTICLE; BONE CELL; BONE MATRIX; BONE REMODELING; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL SURVIVAL; ENDOCRINE SYSTEM; GENE MUTATION; HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ANIMALS; BONE AND BONES; BONE REMODELING; BONE RESORPTION; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HUMANS; OSTEOBLASTS; OSTEOCLASTS; SIGNAL TRANSDUCTION;

EID: 79953149325     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.063032     Document Type: Article

References (104)

1. Akiyama, T., Bouillet, P., Miyazaki, T., Kadono, Y., Chikuda, H., Chung, U. I., Fukuda, A., Hikita, A., Seto, H., Okada, T. et al. (2003). Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22, 6653-6664.
2. Andersen, T. L., Sondergaard, T. E., Skorzynska, K. E., gnaes-Hansen, F., Plesner, T. L., Hauge, E. M., Plesner, T. and Delaisse, J. M. (2009). A physical mechanism for coupling bone resorption and formation in adult human bone. Am. J. Pathol. 174, 239-247.
3. Babij, P., Zhao, W., Small, C., Kharode, Y., Yaworsky, P. J., Bouxsein, M. L., Reddy, P. S., Bodine, P. V., Robinson, J. A., Bhat, B. et al. (2003). High bone mass in mice expressing a mutant LRP5 gene. J. Bone Miner. Res. 18, 960-974.
4. Balemans, W. and Van Hul, W. (2004). Identification of the disease-causing gene in sclerosteosis-discovery of a novel bone anabolic target? J. Musculoskelet. Neuronal Interact. 4, 139-142.
5. Bonewald, L. F. and Johnson, M. L. (2008). Osteocytes, mechanosensing and Wnt signaling. Bone 42, 606-615.
6. Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K. and Lifton, R. P. (2002). High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513-1521.
7. Bradley, E. W., Ruan, M. M. and Oursler, M. J. (2008). Novel pro-survival functions of the Kruppel-like transcription factor Egr2 in promotion of macrophage colony-stimulating factor-mediated osteoclast survival downstream of the MEK/ERK pathway. J. Biol. Chem. 283, 8055-8064.
8. Cao, X. and Chen, D. (2005). The BMP signalling and in vivo bone formation. Gene 357, 1-8.
9. Cardoso, L., Herman, B. C., Verborgt, O., Laudier, D., Majeska, R. J. and Schaffler, M. B. (2009). Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J. Bone Miner. Res. 24, 597-605.
10. Chabadel, A., Banon-Rodriguez, I., Cluet, D., Rudkin, B. B., Wehrle-Haller, B., Genot, E., Jurdic, P., Anton, I. M. and Saltel, F. (2007). CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. Mol. Biol. Cell 18, 4899-4910.
11. Chamoux, E., Couture, J., Bisson, M., Morissette, J., Brown, J. P. and Roux, S. (2009). The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts. Mol. Endocrinol. 23, 1668-1680.
12. Chen, D., Harris, M. A., Rossini, G., Dunstan, C. R., Dallas, S. L., Feng, J. Q., Mundy, G. R. and Harris, S. E. (1997). Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif. Tissue Int. 60, 283-290.
13. Civitelli, R. (2008). Cell-cell communication in the osteoblast/osteocyte lineage. Arch. Biochem. Biophys. 473, 188-192.
14. Civitelli, R., Lecanda, F., Jørgensen, N. R. and Steinberg, T. H. (2002). Intercellular junctions and cell-cell communication in bone. In Principles of Bone Biology (eds. J. P. Bilezikan, L. Raisz and G. A. Rodan), pp. 287-302. San Diego: Academic Press.
15. Coxon, F. P. and Taylor, A. (2008). Vesicular trafficking in osteoclasts. Semin. Cell Dev. Biol. 19, 424-433.
16. Coxon, F. P., Thompson, K. and Rogers, M. J. (2006). Recent advances in understanding the mechanism of action of bisphosphonates. Curr. Opin. Pharmacol. 6, 307-312.
17. Crockett, J. C., Mellis, D. J., Scott, D. I. and Helfrich, M. H. (2011). New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporos. Int. 1, 1-20.
18. Dallas, S. L. and Bonewald, L. F. (2010). Dynamics of the transition from osteoblast to osteocyte. Ann. N. Y. Acad. Sci. 1192, 437-443.
19. Day, T. F., Guo, X., Garrett-Beal, L. and Yang, Y. (2005). Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750.
20. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
21. Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M. et al. (2005). Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514-520.
22. Everts, V., Delaisse, J. M., Korper, W., Jansen, D. C., Tigchelaar-Gutter, W., Saftig, P. and Beertsen, W. (2002). The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J. Bone Miner. Res. 17, 77-90.
23. Everts, V., de Vries, T. J. and Helfrich, M. H. (2009). Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim. Biophys. Acta 1792, 757-765.
24. Ferron, M., We, J., Yoshizawa, T., Del Fattore, A., DePinho, R. A., Teti, A., Ducy, P. and Karsenty, G. (2010). Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 23, 296-308.
25. Fulzele, K., Riddle, R. C., DiGirolamo, D. J., Cao, X., Wan, C., Chen, D., Faugere, M. C., Aja, S., Hussain, M. A., Bruning, J. C. et al. (2010). Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142, 309-319.
26. Glantschnig, H., Hampton, R. A., Lu, P., Zhao, J. Z., Vitelli, S., Huang, L. Haytko, P., Cusick, T., Ireland, C. Jarantow, S. W. et al. (2010). Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo. J. Biol. Chem. 285, 40135-40147.
27. Glass, D. A., 2nd, Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A. et al. (2005). Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764.
28. Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D. et al. (2001). LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523.
29. Govender, S., Csimma, C., Genant, H. K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Börner, M. G. et al. (2002). BMP-2 evaluation in surgery for tibial trauma (BESTT) study group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Joint Surg. Am. 84, 2123-2134.
30. + antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453, 788-792.
31. Guerrini, M. M., Sobacchi, C., Cassani, B., Abinun, M., Kilic, S. S., Pangrazio, A., Moratto, D., Mazzolari, E., Clayton-Smith, J., Orchard, P. et al. (2008). Human osteoclast-poor osteopetrosis with hypogamma-globulinemia due to TNFRSF11A (RANK) mutations. Am. J. Hum. Genet. 83, 64-76.
32. Guo, J., Liu, M., Yang, D., Bouxsein, M. L., Saito, H., Galvin, R. J., Kuhstoss, S. A., Thomas, C. C., Schipani, E., Baron, R. et al. (2010). Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab. 11, 161-171.
33. Heckel, T., Czupalla, C., Expirto Santo, A. I., Anitei, M., Arantzazu Sanchez-Fernandez, M., Mosch, K., Krause, E. and Hoflack, B. (2009). Src-dependent repression of ARF6 is required to maintain podosome-rich sealing zones in bone-digesting osteoclasts. Proc. Natl. Acad. Sci. USA 106, 1451-1456.
34. Helfrich, M. H., Nesbitt, S. A., Dorey, E. L. and Horton, M. A. (1992). Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a (3 integrin. J. Bone Miner. Res. 7, 335-343.
35. Helfrich, M. H., Nesbitt, S. A., Lakkakorpi, P. T., Barnes, M. J., Bodary, S. C., Shankar, G., Mason, W. T., Mendrick, D. L., Väänänen, H. K. et al. (1996). Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone 19, 317-328.
36. Helfrich, M. H., Stenbeck, G., Nesbitt, M. A. and Horton, M. A. (2008). Integrins and adhesion molecules. In Principles of Bone Biology (eds J. P. Bilezikan, L. G. Raisz and T. J. Martin), pp. 385-424. San Diego, Academic Press, Elsevier.
37. Hinoi, E., Gao, N., Jung, D. Y., Yadav, V., Yoshizawa, T., Myers, M. G., Jr, Chua, S. C., Jr, Kim, J. K., Kaestner, K. H. and Karsenty, G. (2008). The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell Biol. 183, 1235-1242.
38. Huesa, C., Helfrich, M. H. and Aspden, R. M. (2009). Parallel-plate fluid flow systems for bone cell stimulation. J. Biomech. 43, 1182-1189.
39. Humphrey, M. B., Lanier, L. L. and Nakamura, M. C. (2005). Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol. Rev. 208, 50-65.
40. Huss, M. and Wieczorek, H. (2009). Inhibitors of V-ATPases: old and new players. J. Exp. Biol. 212, 341-346.
41. Jacobs, C. R., Temiyasathit, S. and Castillo, A. B. (2010). Osteocyte mechanobiology and pericellular mechanics. Annu. Rev. Biomed. Eng. 12, 369-400.
42. Karsdal, M. A., Martin, T. J., Bollerslev, J., Christiansen, C. and Henriksen, K. (2007). Are nonresorbing osteoclasts sources of bone anabolic activity? J. Bone Miner. Res. 22, 487-494.
43. Karsenty, G., Kronenberg, H. M. and Settembre, C. (2009). Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25, 629-648.
44. Kiel, D. P., Demissie, S., Dupuis, J., Lunetta, K. L., Murabito, J. M. and Karasik, D. (2007). Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC. Med. Genet. 8 Suppl. 1, S14.
45. Kornak, U., Kasper, D., Bosl, M. R., Kaiser, E., Schweizer, M., Schulz, A., Friedrich, W., Delling, G. and Jentsch, T. J. (2001). Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205-215.
46. Krum, S. A., Miranda-Carboni, G. A., Hauschka, P. V., Carroll, J. S., Lane, T. F., Freedman, L. P. and Brown, M. (2008). Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27, 535-545.
47. Lakkakorpi, P. T., Horton, M. A., Helfrich, M. H., Karhukorpi, E. K. and Väänänen, H. K. (1991). Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J. Cell Biol. 115, 1179-1186.
48. Lange, P. F., Wartosch, L., Jentsch, T. J. and Fuhrmann, J. C. (2006). ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440, 220-223.
49. Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y. et al. (2007). Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456-469.
50. Leibbrandt, A. and Penninger, J. M. (2008). RANK/RANKL: regulators of immune responses and bone physiology. Ann. N. Y. Acad. Sci. 1143, 123-150.
51. Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R. et al. (2009). Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J. Bone Miner. Res. 24, 578-588.
52. Lian, J. B., Stein, G. S. and Aubin, J. E. (2003). Bone formation: maturation and functional activities of osteoblast lineage cells. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th edn (ed. M. J. Favus), pp. 13-28. Washington, DC: American Society for Bone and Mineral Research.
53. Little, R. D., Carulli, J. P., Del Mastro, R. G., Dupuis, J., Osborne, M., Folz, C., Manning, S. P., Swain, P. M., Zhao, S. C., Eustace, B. et al. (2002). A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11-19.
54. Litzenberger, J. B., Kim, J. B., Tummala, P. and Jacobs, C. R. (2010). Beta1 integrins mediate mechanosensitive signaling pathways in osteocytes. Calcif. Tissue Int. 86, 325-332.
55. Ljusberg, J., Wang, Y., Lang, P., Norgard, M., Dodds, R., Hultenby, K., Ek-Rylander, B. and Andersson, G. (2005). Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J. Biol. Chem. 280, 28370-28381.
56. Luxenburg, C., Geblinger, D., Klein, E., Anderson, K., Hanein, D., Geiger, B. and Addadi, L. (2007). The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS One 2, e179.
57. Manolagas, S. C. and Parfitt, A. M. (2010). What old means to bone. Trends Endocrinol. Metab. 21, 369-374.
58. Marie, P. J. (2002). Role of N-cadherin in bone formation. J. Cell Physiol. 190, 297-305.
59. Martin, T. J., Allan, E. H., Ho, P. W., Gooi, J. H., Quinn, J. M., Gillespie, M. T., Krasnoperov, V. and Sims, N. A. (2010). Communication between EphrinB2 and EphB4 within the osteoblast lineage. Adv. Exp. Med. Biol. 658, 51-60.
60. Matsuo, K. (2010). Eph and ephrin interactions in bone. Adv. Exp. Med. Biol. 658, 95-103.
61. Mbalaviele, G., Shin, C. S. and Civitelli, R. (2006). Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J. Bone Miner. Res. 21, 1821-1827.
62. McNamara, L. M., Majeska, R. J., Weinbaum, S., Friedrich, V. and Schaffler, M. B. (2009). Attachment of osteocyte cell processes to the bone matrix. Anat. Rec. (Hoboken) 292, 355-363.
63. Mulari, M., Vääräniemi, J. and Väänänen, H. K. (2003). Intracellular membrane trafficking in bone resorbing osteoclasts. Microsc. Res. Tech. 61, 496-503.
64. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y. et al. (2007). Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823.
65. Nesbitt, S. A. and Horton, M. A. (1997). Trafficking of matrix collagens through bone resorbing osteoclasts. Science 276, 266-273.
66. Norvell, S. M., Alvarez, M., Bidwell, J. P. and Pavalko, F. M. (2004). Fluid shear stress induces beta-catenin signaling in osteoblasts. Calcif. Tissue Int. 75, 396-404.
67. Novack, D. V. and Faccio, R. (2009). Osteoclast motility: putting the brakes on bone resorption. Ageing Res. Rev. 10, 54-61.
68. Palokangas, H., Mulari, M. and Väänänen, H. K. (1997). Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J. Cell Sci. 110, 1767-1780.
69. Paszty, C., Turner, C. H. and Robinson, M. K. (2010). Sclerostin: a gem from the genome leads to bone-building antibodies. J. Bone Miner. Res. 25, 1897-1904.
70. Pavlos, N. J., Xu, J., Riedel, D., Yeoh, J. S., Teitelbaum, S. L., Papadimitriou, J. M., Jahn, R., Ross, F. P. and Zheng, M. H. (2005). Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol. Cell. Biol. 25, 5253-5269.
71. Pérez-Castrillón, J. L., Pinacho, F., De Luis, D., Lopez-Menendez, M. and Dueñas Laita, A. (2010). Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women. J. Osteoporos. pii: 401581.
72. Quarles, L. D. (2008). Endocrine functions of bone in mineral metabolism regulation. J. Clin. Invest. 118, 3820-3828.
73. Rivadeneira, F., Styrkarsdottir, U., Estrada, K., Halldorsson, B. V., Hsu, Y. H., Richards, J. B., Zillikens, M. C., Kavvoura, F. K., Amin, N., Aulchenko, Y. S. et al. (2009). Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 41, 1199-1206.
74. Rivollier, A., Mazzorana, M., Tebib, J., Piperno, M., Aitsiselmi, T., Rabourdin-Combe, C., Jurdic, P. and Servet-Delprat, C. (2004). Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104, 4029-4037.
75. Rizzoli, R, Yasothan, U. and Kirkpatrick, P. (2010). Denosumab. Nat. Rev. Drug Discov. 9, 591-592.
76. Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E. et al. (2008). Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 283, 5866-5587.
77. Rochefort, G. Y., Pallu, S. and Benhamou, C. L. (2010). Osteocyte: the unrecognised side of bone tissue. Osteoporos. Int. 21, 1457-1469.
78. Rosen, C. J., Ackert-Bicknell, C., Rodriguez, J. P. and Pino, A. M. (2009). Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit. Rev. Eukaryot. Gene Expr. 19, 109-124.
79. Salo, J., Metsikko, K., Palokangas, H., Lehenkari, P. and Väänänen, H. K. (1996). Bone-resorbing osteoclasts reveal a dynamic division of basal plasma membrane into two different domains. J. Cell Sci. 109, 301-307.
80. Salo, J., Lehenkari, P., Mulari, M., Metsikko, K. and Väänänen, H. K. (1997). Removal of osteoclast bone resorption products by transcytosis. Science 276, 270-273.
81. Saltel, F., Destaing, O., Bard, F., Eichert, D. and Jurdic, P. (2004). Apatite-mediated actin dynamics in resorbing osteoclasts. Mol. Biol. Cell 15, 5231-5241.
82. Santos, A., Bakker, A. D., Zandieh-Doulabi, B., de Blieck-Hogervorst, J. M. and Klein-Nulend, J. (2010). Early activation of the beta-catenin pathway in osteocytes is mediated by nitric oxide, phosphatidyl inositol-3 kinase/Akt, and focal adhesion kinase. Biochem. Biophys. Res. Commun. 391, 364-369.
83. Schaller, S., Henriksen, K., Sørensen, M. G. and Karsdal, M. A. (2005). The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment. Drug News Perspect. 18, 489-495.
84. Sobacchi, C., Frattini, A., Guerrini, M. M., Abinun, M., Pangrazio, A., Susani, L., Bredius, R., Mancini, G., Cant, A., Bishop, N. et al. (2007). Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat. Genet. 39, 960-962.
85. Stenbeck, G. (2002). Formation and function of the ruffled border in osteoclasts. Semin. Cell Dev. Biol. 13, 285-292.
86. Sutherland, K. A., Rogers, H. L., Tosh, D. and Rogers, M. J. (2009). RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro. Arthritis Res. Ther. 11, R58.
87. Takada, I., Mihara, M., Suzawa, M., Ohtake, F., Kobayashi, S., Igarashi, M., Youn, M. Y., Takeyama, K., Nakamura, T., Mezaki, Y. et al. (2007). A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat. Cell Biol. 9, 1273-1285.
88. Talmage, R. V. and Elliott, J. R. (1958). Removal of calcium from bone as influenced by the parathyroids. Endocrinology 62, 717-722.
89. Tatsumi, S., Ishii, K., Amizuka, N., Li, M., Kobayashi, T., Kohno, K., Ito, M., Takeshita, S. and Ikeda, K. (2007). Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5, 464-475.
90. Teitelbaum, S. L. (2007). Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170, 427-435.
91. Villa, A., Guerrini, M. M., Cassani, B., Pangrazio, A. and Sobacchi, C., (2009). Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif. Tissue Int. 84, 1-12.
92. Walker, E. C., McGregor, N. E., Poulton, I. J., Pompolo, S., Allan, E. H., Quinn, J. M., Gillespie, M. T., Martin, T. J. and Sims, N. A. (2008). Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J. Bone Miner. Res. 23, 2025-2032.
93. Walker, E. C., McGregor, N. E., Poulton, I. J., Solano, M., Pompolo, S., Fernandes, T. J., Constable, M. J., Nicholson, G. C., Zhang, J. G., Nicola, N. A., et al. (2010). Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J. Clin. Invest. 120, 582-592.
94. Wan, M., Yang, C., Li, J., Wu, X., Yuan, H., Ma, H., He, X., Nie, S., Chang, C. and Cao, X. (2008). Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev. 22, 2968-2979.
95. Wang, Y., McNamara, L. M., Schaffler, M. B. and Weinbaum, S. (2007). A model for the role of integrins in flow induced mechanotransduction in osteocytes. Proc. Natl. Acad. Sci. USA 104, 15941-15946.
96. Weitzmann, M. N. and Pacifici, R. (2007). T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann. N.Y. Acad. Sci. 1116, 360-375.
97. Xing, L. and Boyce, B. F. (2005). Regulation of apoptosis in osteoclasts and osteoblastic cells. Biochem. Biophys. Res. Commun. 328, 709-720.
98. Yadav, V. K., Ryu, J. H., Suda, N., Tanaka, K. F., Gingrich, J. A., Schutz, G., Glorieux, F. H., Chiang, C. Y., Zajac, J. D., Insogna, K. L. et al. (2008). Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135, 825-837.
99. Yadav, V. K., Oury, F., Suda, N., Liu, Z. W., Gao, X. B., Confavreux, C., Klemenhagen, K. C., Tanaka, K. F., Gingrich, J. A., Guo, X. E. et al. (2009). A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138, 976-989.
100. Yamaza, T., Goto, T., Kamiya, T., Kobayashi, Y., Sakai, H. and Tanaka, T. (1998). Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23, 499-509.
101. Zaidi, M., Inzerillo, A. M., Moonga, B. S., Bevis, P. J. and Huang, C. L. (2002). Forty years of calcitonin-where are we now? A tribute to the work of Iain Macintyre, FRS. Bone 30, 655-663.
102. Zaman, G., Jessop, H. L., Muzylak, M., De Souza, R. L., Pitsillides, A. A., Price, J. S. and Lanyon, L. L. (2006). Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen. J. Bone Miner. Res. 21, 1297-1306.
103. Zhao, H., Laitala-Leinonen, T., Parikka, V. and Vaananen, H. K. (2001). Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J. Biol. Chem. 276, 39295-39302.
104. Zimmerman, D., Jin, F., Leboy, P., Hardy, S. and Damsky, C. (2000). Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts. Dev. Biol. 220, 2-15.